Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check6 days agoChange DetectedTwo screenshots show only layout and styling tweaks with the study details remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check13 days agoChange DetectedMelanoma and MedlinePlus Genetics related topics were added to the study page to enhance navigation and topic discovery. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoChange Detected- Added MedlinePlus Genetics topic coverage focusing on melanoma, expanding core content and mentioning a specific condition. No deletions were observed.SummaryDifference0.2%

- Check27 days agoChange Detected**Change summary:** Removed the MedlinePlus Genetics topic on Melanoma, narrowing the page's topic coverage related to melanoma within genetics content.SummaryDifference0.2%

- Check34 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check42 days agoChange DetectedUpdated the page to a new revision (v3.1.0) and added MedlinePlus Genetics content on Melanoma, replacing the previous revision v3.0.2.SummaryDifference0.3%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.